相关实验视频

Updated: Jul 19, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

在默克尔细胞癌中,miRNAs驱动诊断,预后和进展

Tohada M Al-Noshokaty¹, Mohammed S Elballal², Gouda Kamel Helal³

¹Biochemistry Department, Faculty of Pharmacy, Heliopolis University, Cairo 11785, Egypt.

Pathology, research and practice

|August 18, 2023

概括

默克尔细胞癌 (MCC) 是一种罕见的皮肤癌,治疗选择有限. 微RNAs (miRNAs) 显示为改善MCC管理的诊断和预后生物标志物具有前途.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

默克尔细胞癌 (MCC) 是一种罕见的,具有高复发率和日益增加的发病率的侵袭性皮肤癌.
目前对MCC的诊断,评估和治疗选择有限.
微RNAs (miRNAs) 是小的,非编码RNA分子,在细胞生物学和癌症发育中至关重要,作为瘤抑制剂或瘤Rs.

研究的目的:

汇编,总结和讨论关于默克尔细胞癌 (MCC) 中微RNA (miRNA) 的最新研究.
强调miRNAs作为MCC的诊断和预后生物标志物的潜在临床实用性.

主要方法:

文献综述和对MCC中miRNAs的最新研究的综合.
在MCC组织和细胞系中分析miRNA表达模式.
评估特定miRNAs在MCC病原和进展中的作用.

主要成果:

在MCC中观察到特定miRNAs的异常表达.
某些miRNAs作为瘤抑制剂,而另一些则在MCC中作为oncomiRs.
新出现的证据表明miRNAs可以成为MCC诊断和预后的潜在生物标志物.

结论:

微RNA对提高MCC的诊断,预后和治疗策略具有显著的前景.
对miRNA生物标志物的进一步研究可能会导致改善默克尔细胞癌患者的治疗结果.
向miRNA可能为这种侵袭性皮肤恶性瘤提供新的治疗途径.

关键词:

诊断诊断诊断诊断诊断在MCC中,MCC是MCC,MCC是MCC.梅克尔细胞癌瘤是什么?微型RNAs,生物标志物预测预后预测预测

更多相关视频

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization

Published on: June 7, 2016

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...